Abstracts Archive - Page 346 of 1683 - ATC Abstracts

2020 American Transplant Congress
The Safety and Effectiveness and of Isoniazid Empirical Prophylaxis Compared to Screening Based Prophylaxis Post Lung Transplantation
G. B. Korayem¹, R. S. Almaghrabi², N. I. AlSuhaibani¹, G. S. AlSwailem¹, M. A. AlShammari¹, D. A. Aleissa³
¹Pharmacy Practice Department, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia, ²Section of Infectious Diseases, Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia, ³Transplant Clinical Pharmacist, Pharmaceutical Care Division, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
*Purpose: Even though guidelines recommend using isoniazid (INH) for TB prophylaxis depending on donors and recipients’ screening tests, previous studies supported its use in all…
2020 American Transplant Congress
Transpulmonary Gradient as a Predictor for Outcomes after Single Lung Transplantation in Patients with Pulmonary Hypertension
A. Madde¹, E. Chan², J. Ryan², P. Reck Dos Santos², M. Morrell³, J. Luketich², P. Sanchez²
¹University of Pittsburgh School of Medicine, Pittsburgh, PA, ²UPMC Department of Cardiothoracic Surgery, Pittsburgh, PA, ³UPMC Division of Pulmonary Medicine, Pittsburgh, PA
*Purpose: End stage lung disease is commonly associated with pulmonary artery hypertension (PAH). In a donor restrictive environment, offering patients single over double lung transplants…
2020 American Transplant Congress
Alternate Triazole Therapy for Breakthrough Invasive Fungal Disease in Lung Transplant Recipients on Triazole Prophylaxis
A. Abbas, H. Hassouna, F. Marco Canosa, K. D. Brizendine
Cleveland Clinic Foundation, Cleveland, OH
*Purpose: Invasive fungal diseases (IFD) are a leading cause of infection related morbidity and mortality in lung transplant (LT) recipients. Data regarding outcomes of breakthrough…
2020 American Transplant Congress
The Relationship Between Frailty and Performance Status in Patients with Cirrhosis Awaiting Liver Transplantation
C. Q. Xu¹, F. Yao², Y. Mohamad², R. Wong², D. Kent², S. Seetharaman², Y. Srisengfa², J. C. Lai²
¹Department of Medicine, UCSF, San Francisco, CA, ²Division of Gastroenterology and Hepatology, Department of Medicine, UCSF, San Francisco, CA
*Purpose: Frailty—a multi-dimensional construct that encapsulates physical function, performance status, and nutritional status—has emerged as a critical determinant of mortality in patients with cirrhosis. Currently,…
2020 American Transplant Congress
Heart Transplantation Outcomes in Patients with Marfan Syndrome: A UNOS Registry Analysis
P. Genyk¹, K. Yang¹, J. Pizula¹, A. Lee¹, D. Miklin¹, S. Shah¹, S. Nuno¹, S. Hashmi¹, J. Nattiv¹, A. Kiankhooy¹, L. Grazette¹, M. Fong¹, J. Rahman¹, K. Pandya¹, A. Vaidya¹, D. Vucicevic², J. Li¹, P. Kingsford¹, P. Banankhah¹, A. Wolfson³, G. Liu¹, R. Chand⁴, E. Depasquale¹
¹Keck Medicine of USC, Los Angeles, CA, ²Newark Beth-Israel Medical Center, Newark, NJ, ³University of Arizona Sarver Heart Center, Tucson, AZ, ⁴Harbor-UCLA Medical Center, Torrance, CA
*Purpose: Marfan syndrome (MS) is an autosomal dominant connective tissue disorder due to a defect in the fibrillin-1 gene. MS patients can develop a discrete…
2020 American Transplant Congress
A NASHional Crisis: Liver Transplantation Outcomes in Female Hispanics
R. A. Sosa¹, A. Q. Terry¹, M. Rossetti¹, F. M. Kaldas², B. V. Naini¹, J. Nevarez-Mejia¹, V. M. Groysberg¹, S. Younan², R. W. Busuttil², D. W. Gjertson¹, J. W. Kupiec-Weglinski², E. F. Reed¹
¹Pathology and Lab Medicine, UCLA, Los Angeles, CA, ²Surgery, UCLA, Los Angeles, CA
*Purpose: Obesity and metabolic syndrome have recently become an epidemic with Hispanics bearing a disproportionate burden. Non-alcoholic steatohepatitis (NASH) is a severe immune-mediated stage of…
2020 American Transplant Congress
Resilience in Heart Transplant Candidates
Y. T. Bui¹, D. S. Yip², B. W. Hardaway³, S. M. Dunlay⁴, S. Jowsey-Gregoire⁵, R. Benzo⁶, R. C. Daly⁷, M. A. Hathcock⁸, K. Thompson⁹, C. C. Kennedy¹⁰
¹Mayo Clinic Alix School of Medicine, Rochester, MN, ²Department of Transplantation, Mayo Clinic, Jacksonville, FL, ³Division of Cardiovascular Diseases, Mayo Clinic, Scottsdale, AZ, ⁴Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, ⁵Department of Psychiatry, Mayo Clinic, Rochester, MN, ⁶Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, ⁷Division of Cardiovascular Surgery, Mayo Clinic, Rochester, MN, ⁸Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, ⁹Pulmonary Clinical Research Unit, Mayo Clinic, Rochester, MN, ¹⁰William J. von Liebig Center for Transplantation and Regenerative Medicine, Mayo Clinic, Rochester, MN
*Purpose: Resilience is the capacity to adapt to or recover from adverse experiences. Our objective was to measure resilience in waitlisted, adult heart transplant candidates…
2020 American Transplant Congress
The Reperfusion Response in Plasma of Combined Heart/ Lung Transplanted Patients is Guided by Heart-Associated Cytokine Patterns on Contrast to the Ischemic Injury in Perfusion Solutions Following a Lung-Associated Pattern
C. Falk¹, J. Kühne², L. Radomsky², F. Wandrer², B. Wiegmann³, N. Ledwoch², J. Keil², K. Beushausen², F. Ius³, W. Sommer³, S. Rojas-Hernandez³, I. Tudorache³, A. Haverich³, G. Warnecke³
¹MHH, Institute of Transplant Immunology, Hannover, Germany, ²Institute of Transplant Immunology, Hannover Medical School MHH, Hannover, Germany, ³Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School MHH, Hannover, Germany
*Purpose: Organ-specific differences are discussed for ischemia/reperfusion injury (IRI) in cardiothoracic transplantation but rarely compared directly in a clinical setting. Therefore, we compared a cohort…
2020 American Transplant Congress
Assessment of HEALTh LIteracy on MEdication ADheREnce and Graft Outcomes in KIdney Transplant Recipients (Hallmark)
M. Leung¹, A. Dhanda², S. Kwan³, A. Zienkiewicz³, E. Waters³, N. Wood³, L. Young³, C. Bannon³
¹Pharmacy, St. Paul's Hospital, Vancouver, BC, Canada, ²Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada, ³Nephrology, St. Paul's Hospital, Vancouver, BC, Canada
*Purpose: Upon successful kidney transplantation, many patients have difficulty adhering to their new immunosuppression medication regimens. Previous studies have established low health literacy to be…
2020 American Transplant Congress
Correlation of CMV and EBV DNAemia in the Development of Invasive Fungal Disease among Pediatric Intestinal and Liver Transplant Recipients
B. M. Chatani¹, J. Garcia², T. Beduschi³, A. Tekin³, R. Vianna³, I. A. Gonzalez¹
¹Pediatric Infectious Disease, University of Miami Miller School of Medicine, Miami, FL, ²Pediatric Gastroenterology, University of Miami Miller School of Medicine, Miami, FL, ³Miami Transplant Institute, Miami, FL
*Purpose: Invasive fungal disease (IFD) among pediatric solid organ transplant recipients is a relatively rare event, however often results in death. There are many factors…